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Abstract
Background: Journal impact factors and their ranks are used widely by journals, researchers, and
research assessment exercises.
Methods: Based on citations to journals in research and experimental medicine in 2005, Bayesian
Markov chain Monte Carlo methods were used to estimate the uncertainty associated with these
journal performance indicators.
Results: Intervals representing plausible ranges of values for journal impact factor ranks indicated
that most journals cannot be ranked with great precision. Only the top and bottom few journals
could place any confidence in their rank position. Intervals were wider and overlapping for most
journals.
Conclusion: Decisions placed on journal impact factors are potentially misleading where the
uncertainty associated with the measure is ignored. This article proposes that caution should be
exercised in the interpretation of journal impact factors and their ranks, and specifically that a
measure of uncertainty should be routinely presented alongside the point estimate.
Background
Journal citation reports are used widely as the basis for
assessing research output. They are used by funding bod-
ies to gauge the quality of publications, by researchers to
assess which journals they choose to submit manuscripts
to, and as a basis for journals to attract new subscriptions
and advertising [1]. In addition, current discussion sur-
rounding the future nature of the UK Research Assessment
Exercise (RAE) involves greater use of such bibliometric
data [2,3]. The journal impact factor is the most widely
cited bibliometric tool used to characterise journals. It was
originally proposed 50 years ago as a measure of the
impact that individual articles have on the research com-
munity [4], but it is now more commonly used across all
articles published by a journal to provide a measure of a
journal's impact on the research community rather than
the impact of an individual article [5]. The journal impact
factor is thus calculated as the number of citations a jour-
nal has received in the last complete year for articles pub-
lished in the two preceding years, divided by the total
number of articles the journal published in the two pre-
ceding years. So it gives an average number of citations of
published articles, without giving any unfair advantage to
the larger or more frequently published journals.
Many journals have taken to quoting their impact factor
rank compared with other journals in the same field [1,5].
For example, Nature Medicine, with a journal impact factor
of 28.9 is currently ranked number one in terms of its
impact factor in the field of research and experimental
medicine based on the 2005 Journal Citation Reports,
whilst BMC Medical Research Methodology currently adver-
tises an unofficial journal impact factor of 1.58 based on
citations in 2006, which would rank it approximately 45th
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There has been considerable discussion regarding the
merits and weaknesses of the journal impact factor [1,6-
18] but very little comment on the precision with which
they are quoted [1,19,20].
The underlying rate at which any particular article is cited
is subject to sampling error, as is the underlying rank.
These figures are used without regard to the uncertainty
attached to their estimation, violating many journals' own
guidelines for presentation of point estimates within the
research articles that they publish [21]. Previous studies
have shown that when confidence intervals are used for
performance indicators, especially for ranks, the degree of
uncertainty associated with such estimates is such that
very little credence can be given to them [22-25]. In this
article I have therefore explored the hypothesis that there
is similar uncertainty associated with journal rankings
based on the journal impact factor. The strength of evi-
dence for the ranking of journals is investigated for the
journal citation reports category of "medicine, research
and experimental", based on citations in the most recent
complete year of Journal Citation Reports, 2005.
Methods
The number of citations in 2005 to articles published in
2003 and 2004, and the number of articles published in
2003 and 2004 was sourced from the Web of Science [26]
for all journals listed under the category of "medicine,
research and experimental".
A random effects Poisson model allowing for over-disper-
sion was fitted within a Bayesian framework using Markov
chain Monte Carlo (MCMC) methods in WinBUGS 1.4
[27]. This overcomes problems of small samples by pool-
ing information from each journal and provides more
reliable estimates [24,28]. The observed frequency of cita-
tions Oi for journal i in the two years preceding the year
the journal impact factor refers to was assumed to follow
a Poisson distribution. If ni is the number of articles pub-
lished by journal i during that time period, and λi is the
underlying citation rate per article for journal i (the jour-
nal impact factor), then we assume the model Oi ~
Pois(λini), where ln(λi) = ln(λ) + υi and random effect υi ~
N(0, σ2) to allow for over-dispersion.
The overall geometric mean citation rate is represented by
λ. This was given a minimally informative but proper
prior ~ N(0.01, 1000). The precision of the random effect
(1/σ2) was given an uninformative gamma prior ~
Γ(0.001, 0.001). In this way the heterogeneity between
journals is modelled and the underlying distribution of
citation rates can be characterised. Using MCMC it was
also possible to rank the parameter realizations from the
posterior distribution to give mean or median ranks with
associated 95% credible intervals. The credible interval
indicates the plausible range of values within which the
true journal rank lies and is the Bayesian equivalent of a
confidence interval.
Results
Convergence to a stationary distribution appeared to be
achieved after a 25,000 update burn-in. Adequate mixing
and convergence was confirmed by assessment of trace
plots and Brooks-Gelman-Rubin statistics [29]. This was
followed by a further 50,000 updates for each chain to
give Monte Carlo error for each parameter of interest less
than 5 percent of the sample standard deviation. The
underlying citation rate for each journal, λi (the underly-
ing journal impact factor), taken as the mean over the
updates for each parameter, together with the uncertainty
associated with its estimation, provided by 95% credible
intervals, is shown for research and experimental medi-
cine journals in figure 1. The intervals overlap for a large
proportion of the journals. The rates show the usual slight
shrinkage whenever a random effects model is used. The
mean rank associated with each of the underlying journal
impact factors are shown in figure 2. Again, there is con-
siderable overlap of the plausible range of ranks for all
journals other than those in the top or bottom few ranks.
Over all journals, the mean width of 95% credible interval
for the journal impact factor ranks is 7 places, with the
widest plausible range of ranks being 15 places for one
journal. The credible intervals for the journals ranked in
the top three are narrow and the top journal has a 95%
credible interval of (1 to 1). For the middle ranked jour-
nals the intervals are somewhat wider, with greater over-
lap.
Discussion
The top three journals can be confident that their impact
factor rank is fairly precise, with the top journals having
no overlap with the lesser journals. For the majority of
journals further down the table, the ranking of journals
with lower impact factors has less certainty attached to it
and their ranking can only be confidently placed within
quite a wide range. For example, a journal's impact factor
ranking could easily vary by 10 or so positions, without
implying any meaningful change in citation performance.
The width of intervals for other research areas will depend
in part on the number of citations, reflecting the activity
in the research community. For example, for journals in
the field of probability and statistics a journal's impact
factor ranking could easily vary by 20 or 30 positions,
equivalent to ranging over one quarter or one third of the
table. Other bibliometric measures, such as the immedi-
acy index, are based on citations in a shorter period of
time. These measures will have much wider credible inter-Page 2 of 6
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ble intervals around their ranks.
A total of 19,393 articles were published in the area of
research and experimental medicine during the years cov-
ered. It was therefore beyond the scope of this project to
extract information on each of these individual articles.
This additional information would allow variation at the
level of the individual article (within journal variability)
to be taken into account, thus increasing the width of the
credible intervals, and allowing further exploration of the
potential problems of taking the journal impact factor to
be the mean of a highly skewed distribution [15]. How-
ever, by modelling the counts as a Poisson distribution,
the confidence intervals are valid for the measure used.
It is now well established that ranking institutional per-
formance such as school examination scores or hospital
mortality rates, and ranking individual performance such
as a surgeon's success rate, is subject to considerable
uncertainty [22-25]. This uncertainty must be taken into
account before comparison can be made and inferences
drawn [22,23,25]. The Royal Statistical Society has itself
published guidelines on the use of such performance indi-
cators, stating that "league tables without demonstration
of ranking uncertainty should be avoided and, even with
uncertainty incorporated, such tables should be used with
considerable caution" [30]. The journal impact factor is
analogous to a performance indicator for journals, and as
such many of the recommendations for performance indi-
cators could equally be applied to the use of journal
impact factors. In particular, a measure of uncertainty
should be presented alongside a journal impact factor
ranking.
The figures presented appear to show less uncertainty in
the ranks, and associated narrower plausible ranges
around the ranks, than those investigated to date in the
Underlying journal impact factors with 95% credible interval for journals in research and experimental medicineFigure 1
Underlying journal impact factors with 95% credible interval for journals in research and experimental medicine. Source: Web 
of Science, Thomson Scientific, accessed April 3, 2007.
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large number of citations that some journals receive.
However, this will depend to a large extent on the research
discipline covered by the journal, and some disciplines
may demonstrate greater or less uncertainty than the cate-
gory of research and experimental medicine. For example,
in the category of probability and statistics, intervals are
much wider, demonstrating greater uncertainty in the esti-
mates.
The implications for the use of bibliometric measures is
that decisions based purely on ranks should be avoided.
Less emphasis should be placed on small differences in
rank order because this may be attributable to random
variation. This suggests that arbitrary cut-offs or thresh-
olds should be avoided when making decisions, as there
will be very little difference in the underlying citation rate
for journals either side of the cut-off. Journals whose
impact factors and ranks are broadly similar should be
treated similarly, no matter which side of an artificial
divide they are placed, because these measures are esti-
mated with considerable uncertainty. Instead, the meas-
ure should be kept as a continuous scale so that small
differences between journals are associated with similar
decisions.
It might be argued that there is no uncertainty associated
with the journal impact factor, because it is based on a
census of all publications over a given period, and is there-
fore free from sampling error. However, the main purpose
of quoting the journal impact factor is as a performance
indicator, drawing inference about the general impact of
the journal. This, then, use the journal impact factor as a
measure of the underlying rate at which any particular
article in the journal is cited. This rate is unknown and
must be estimated subject to sampling error. It therefore
requires a measure of the uncertainty associated with the
estimate.
Mean rank of underlying journal impact factor with 95% credible interval for journals in research and experimental medicineFigure 2
Mean rank of underlying journal impact factor with 95% credible interval for journals in research and experimental medicine. 
Source: Web of Science, Thomson Scientific, accessed April 3, 2007.
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requirements for manuscripts submitted to biomedical
journals [21]. These state that measures of uncertainty,
such as confidence intervals, should be presented along-
side estimates. This is echoed by most modern textbooks
on research methods in medicine. Given that important
funding and employment decisions are often based on the
estimated impact factors of journals in which researchers
publish their work, and on the journal impact factor
ranks, an additional useful tool for the researcher would
be to know how much uncertainty existed in the biblio-
metric measure on which they base their decisions. This
article therefore proposes that a plausible range, such as a
credible interval, be used alongside the estimated journal
impact factor and its rank.
This proposal also applies to other journal performance
indicators that may be used. For example, the immediacy
index is the number of citations received by a journal in
the last complete year, divided by the number of articles
published by that journal in that year. It therefore gives a
measure of how quickly articles from a journal are cited.
Like the journal impact factor, it avoids any advantage to
larger journals, but it may advantage those that publish
more frequently. This measure has more uncertainty asso-
ciated with it than for the journal impact factor (data not
shown) because it is based on a shorter time period. Even
if only broad banding of journal immediacy index ranks
are used, most journals outside the top ones could not
confidently identify whether they were ranked in the top
or bottom halves of the table.
Conclusion
There are strong similarities between the use of journal
impact factor ranks and the league tables used to present
performance indicators for hospitals and schools [22-
25,30]. Both suffer from the potential for comparisons
based on ranks to be misleading. The strength of the work
presented in this paper is to quantify the lack of precision
in journal impact factor ranks and highlight the care that
must be taken in their use.
The implication for journals, researchers and advertisers is
that only limited confidence should be placed on the
ranking of these indicators. Decisions placed on such
measures are potentially misleading where the uncer-
tainty associated with the measure is ignored. Journals
should follow their own guidelines for presenting data
[21] by including a measure of uncertainty when quoting
performance indicators such as the journal impact factor
or immediacy index.
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